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The senescence state induced by the oncogenic activation of the p53 and retinoblastoma
(pRb) pathways is likely an important mechanism for preventing the proliferation of
potential cancer cells (1, 2). Senescent cells exit the cell cycle and undergo major changes in
chromatin structure that are thought to render senescence irreversible. Despite the absence of
proliferation, senescent cells are not as quiescent as first thought, as they signal to their
surrounding environment by activating a secretory program (3, 4). On page xx of this issue,
Narita et al provide evidence that in order to enable this secretory state, senescent cells must
profoundly reorganize their endomembrane system.
The secretory program leads to the massive production of factors [collectively termed the
senescence messaging secretome (SMS) or senescence associated secretory phenotype
(SASP)] that are released into the surrounding microenvironment (3, 4). The composition of
the SMS is heterogeneous, as it includes growth factors, inflammatory cytokines, and
modulators of the extracellular matrix, and its precise physiological role is highly
controversial. For example, inflammation can modify the microenvironment in ways that
favor invasion and tumor growth (5, 6); however, in the context of oncogene-induced
senescence, inflammatory cytokines also appear to exert an autocrine, tumor-suppressive
action (7–10).
Narita et al find that H-RasV12-induced senescence triggers a reorganization of the
endomembrane system of senescent cells, which results in the formation of a novel
membrane compartment that carries out the SMS. Narita et al name this novel structure the
‘TOR-Autophagy Spatial Coupling Compartment’, or TASCC. As the name suggests, the
key ingredients of this compartment are autophagosomes and the mTOR Complex 1
(mTORC1) kinase. In the proposed model autophagosomes, by degrading aged organelles
and proteins, generate a high flux of amino acids and other metabolites that provide building
blocks for biosynthesis (11). mTORC1 promotes the utilization of these metabolites for the
synthesis of the SMS components. The secret to this highly efficient process resides,
according to the authors, in the tight spatial coupling of autophagy and mTORC1; in cells
undergoing RIS, they find a large accumulation of mTORC1-studded lysosomes together
with autophagosomes in a well-defined perinuclear location.
In support of their model, Narita et al find that blocking the localization of mTORC1 to the
TASCC via knock down of the Rag GTPases (which recruit mTORC1 to the lysosomal
surface in response to amino acids (12)) results in a strong reduction in the synthesis and
secretion of two key SMS components, IL6 and IL8. Moreover, blocking autophagy, and
thus cutting off the amino acid supply that activates mTORC1, leads to complete loss of
mTORC1 from the TASCC.
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While bringing together autophagy and mTORC1 seems like a smart way to increase the
secretory output of cells, it also poses a logical problem; activated mTORC1 is a potent
suppressor of autophagy, via its ability to phosphorylate and inhibit key autophagy initiators,
including the ULK1 kinase (11). In fact rapamycin, an inhibitor of mTORC1, induces
autophagy even when cells are in a nutrient-rich environment. In order to explain this
apparent paradox, the authors analyze the subcellular distribution of epitope-tagged ULK1
and, interestingly, find that it appears to be excluded from the TASCC. Moreover, using a
‘traffic light’ reporter of autophagosome maturation, they observe that the TASCC mainly
contains mature autophagosomes, while early autophagosomes are mostly outside the
TASCC. Thus, in senescent cells, autophagosomes form outside the TASCC, out of reach
from the inhibitory action of mTORC1, but they progressively move inward as they mature.
This finding has broad implications, as it suggests that spatial segregation of mTORC1 from
autophagy-initiating factors may enable the maintenance of basal autophagy in actively
growing cells.
Supporting a key role for the TASCC in driving the secretory activity of senescent cells,
ultrastructural analyses reveal a close apposition of the TASCC with elements of the
endoplasmic reticulum, Golgi apparatus, and trans-Golgi network. Moreover, Narita et al
use click chemistry to label nascent polypeptides and follow their fate; they find that newly-
synthesized proteins are enriched in the TGN within 30 minutes of their synthesis, but
accumulate in the TASCC shortly afterwards. Thus, a continuous flow of newly-synthesized
proteins traverses the secretory pathway and ends up in the TASCC; this extremely rapid
protein turnover may be key in fueling the synthesis of SMS components.
A key unanswered issue is whether senescence upregulates the activity of the secretory
pathway as a whole, or whether it selectively boosts the translation and secretion of the SMS
components alone. The high rate of protein turnover, together with the elevated autophagic
activity, suggests a scenario where the synthesis of many protein species may be
nonselectively upregulated during RIS; however, most of these proteins would be destined
for immediate degradation, while only SMS components would be selectively secreted. This
seemingly wasteful mechanism may underlie a broader function for the TASCC in non-
senescent physiological settings; in fact, Narita et al identify TASCC-like structures in
leukemia cells undergoing differentiation, as well as in renal glomerular cells in vivo. Thus,
it is conceivable that multiple mechanisms could set up the TASCC and enhance general
secretory activity, but the nature of the proteins being stabilized and secreted may be
context-specific.
In conclusion, Narita et al reveal the surprising ability of senescent cells to reorganize the
morphology and the function of their endomembrane system. Their findings bring forth
some exciting questions; in particular, what are the mechanism(s) that lead to formation of
the TASCC? Are there senescence-associated gene expression programs that control
membrane organization and dynamics? Are H-Ras and/or p53 directly involved? Answers to
these questions are likely to shed light on the role of the TASCC in the maintenance of the
senescent state and in tumor suppression.
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Figure 1. The TASCC enhances synthesis and secretion of SMS components during Ras-induced
senescence
In normal cells growing in nutrient-rich medium (left) autophagy is suppressed, among other
mechanisms, by mTORC1-mediated phosphorylation of ULK1. In cells undergoing Ras-
induced senescence (right), massive autophagosome formation initiates at the cell periphery
(A). This may be due to the massive recruitment of mTORC1-positive lysosomes in the
vicinity of the nucleus (B), resulting in de-inhibition of ULK1 at more distal locations. As
autophagosomes mature, they fuse with mTORC1-positive lysosomes, giving rise to the
TASCC (B). The flow of amino acids and other metabolites from autophagolysosomes
activates mTORC1 (C), and also provides basic building blocks for protein synthesis. As a
consequence, production of SMS components is upregulated at the endoplasmic reticulum
and Golgi apparatus (D). Finally, SMS components are packaged into secretory vesicles at
the trans-Golgi network and sent toward the plasma membrane (E); however, some newly-
synthesized proteins are re-routed to the TASCC and rapidly degraded to fuel further rounds
of protein synthesis. Abbreviations: TASCC = TOR-Autophagy Spatial Coupling
Compartment; ER = endoplasmic reticulum; GA = Golgi apparatus;
TGN = trans-Golgi network.
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